HQ Function

Served as the primary center for research and development, corporate operations, and strategic planning for its antibacterial drug pipeline before being integrated into Innoviva.

Notable Features:

The facility housed advanced laboratory spaces designed for microbiological research, medicinal chemistry, and biopharmaceutical development.

Work Culture:

Prior to acquisition, Entasis fostered a science-driven, innovative, and collaborative environment. Employees were deeply committed to the mission of combating antimicrobial resistance and developing novel therapies for patients with critical infections.

HQ Significance:

The Waltham headquarters was the core of Entasis's R&D engine, driving the progression of its novel antibiotic candidates from discovery through clinical trials.

Values Reflected in HQ: The headquarters reflected values of scientific rigor, innovation in drug discovery, patient-centricity, and a sense of urgency in addressing the global threat of antibiotic-resistant infections.

Location:

Before its acquisition by Innoviva, Entasis Therapeutics's global presence was mainly characterized by its efforts to address worldwide health challenges posed by antimicrobial resistance. This involved conducting international clinical trials for its drug candidates, such as SUL-DUR and zoliflodacin, across various countries to ensure diverse patient data and meet global regulatory standards for potential commercialization. Research collaborations and partnerships also extended its scientific reach internationally.

Street Address:

35 Gatehouse Drive

City:

Waltham

State/Province:

MA

Country:

USA